Stock doesn't have any Revenue Forecast Data
Sun Pharma Adv Res. - Sun Pharma Advanced Research Company Share Price
Loading...
| Open | 204.99 |
| High | 213.00 |
| Low | 202.19 |
| Prev Close | 205.92 |
| Volume | 22,62,905 |
| VWAP(₹) | 207.69 |
Key Metrics
| PE Ratio(x) | 4.26 |
| EPS - TTM(₹) | 47.86 |
| MCap(₹ Cr.) | 6,623.81 |
| MCap Rank | 56 |
| PB Ratio(x) | 4.99 |
| Div Yield(%) | - |
| Face Value(₹) | 1.00 |
| 52W High(₹) | 248.75 |
| 52W Low(₹) | 108.00 |
| MCap/Sales | 1.98 |
| Beta(1 Month) | 0.72 |
| BV/Share(₹) | 41.26 |
Sun Pharma Adv Res. share price insights
ROE Outperforming 5 Year Average
Company delivered ROE of 116.38% in year ending Mar 31, 2026 outperforming its 5 year avg. of 22.05%. (Source: Standalone Financials)PAT: Entering the Green
Company has posted a profit of Rs 1761.34 cr in Mar 31, 2026 quarter after 3 consecutive quarter of losses. (Source: Consolidated Financials)Quarterly Topline Performance
Company witnessed QoQ revenue growth of 21852.9%, which is highest in the last 3 years. (Source: Standalone Financials)Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 2469.6% outperformed its 3 year CAGR of 95.04%. (Source: Consolidated Financials)Sun Pharma Adv Res. Share Price Update
Sun Pharma Advanced Research Company Ltd. share price moved down by -0.88% from its previous close of Rs 205.92. Sun Pharma Advanced Research Company Ltd. stock last traded price is 204.11
Share Price Value Today/Current/Last 204.11 Previous Day 205.92
Found Insights useful?
Sun Pharma Adv Res. Share Price Returns
| 1 Day | -0.88% |
| 1 Month | 21.17% |
| 3 Months | 62.57% |
| 1 Year | 23.11% |
| 3 Years | 7.99% |
| 5 Years | -17.86% |
Sun Pharma Adv Res. Share Recommendations
Mean recosCurrent
STRONG BUY
2 Analysts
Strong
SellSellHoldBuyStrong
Buy
SellSellHoldBuyStrong
Buy
Analyst Trends
| Ratings | Current | 1W Ago | 1M Ago | 3M Ago |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 |
| Hold | - | - | - | - |
| Sell | - | - | - | - |
| Strong Sell | - | - | - | - |
| # Analysts | 2 | 2 | 2 | 2 |
Recent Recos
- Target₹220
- OrganizationAngel One Ltd
- BUY
- Target₹370
- OrganizationAxis Securities
- BUY
- Target₹345
- OrganizationYes Securities
- BUY
News & Analysis
News
Sun Pharma Advanced Research jumps 11%, extends 2-day rally as US court clears Sezaby PRV
News
BSE500 slumps 1.3% week-on-week led by IndusInd Bank crash. IT worst sectoral performer
News
These 8 stocks have tumbled over 40% in FY25 so farStatutory Auditors Certificate In Terms Of Regulation 169(5) Of SEBI ICDRA Regulation..
Announcements
Financials
Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Total Income 1,855.02 8.45 7.87 18.78 27.19 Total Income Growth (%) 0.00 7.37 -58.09 -30.93 80.07 Total Expenses 82.42 80.02 76.14 64.40 83.32 Total Expenses Growth (%) 3.00 5.10 18.23 -22.71 -9.18 EBIT 1,772.60 -71.57 -68.27 -45.62 -56.13 EBIT Growth (%) - - - - - Profit after Tax (PAT) 1,761.34 -80.42 -75.85 -51.87 -59.77 PAT Growth (%) - - - - - EBIT Margin (%) 95.56 -846.98 -867.47 -242.92 -206.44 Net Profit Margin (%) 94.95 -951.72 -963.79 -276.20 -219.82 Basic EPS (₹) 54.27 -2.48 -2.34 -1.60 -1.84 All figures in Rs Cr, unless mentioned otherwise
InsightsPAT: Entering the Green
Company has posted a profit of Rs 1761.34 cr in Mar 31, 2026 quarter after 3 consecutive quarter of losses. (Source: Consolidated Financials)Quarterly Topline Performance
Company witnessed QoQ revenue growth of 21852.9%, which is highest in the last 3 years. (Source: Standalone Financials)
Annual FY 2026 FY 2025 FY 2024 Total Assets 2,170.86 335.53 515.04 Total Assets Growth (%) 546.99 -34.85 -37.96 Total Liabilities 832.04 552.48 389.29 Total Liabilities Growth (%) 50.60 41.92 22.67 Total Equity 1,338.82 -216.95 125.76 Total Equity Growth (%) - -272.52 -75.48 Current Ratio (x) 2.47 0.07 1.02 Total Debt to Equity (x) 0.42 -1.19 0.37 Contingent Liabilities 0.00 407.82 420.56 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2026 FY 2025 FY 2024 Net Cash flow from Operating Activities -238.77 -360.29 -429.19 Net Cash used in Investing Activities -23.50 157.66 391.53 Net Cash flow from Financing Activities 261.39 199.26 42.41 Net Cash Flow -0.80 -3.37 4.75 Closing Cash & Cash Equivalent 1.16 1.96 5.33 Closing Cash & Cash Equivalent Growth (%) -40.93 -63.15 813.21 Total Debt/ CFO (x) -2.33 -0.72 -0.11 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2026 FY 2025 FY 2024 Return on Equity (%) 116.01 0.00 -307.91 Return on Capital Employed (%) 112.89 862.23 -154.06 Return on Assets (%) 71.54 -102.07 -75.18 Interest Coverage Ratio (x) 47.16 -35.55 -219.89 Asset Turnover Ratio (x) 1.50 0.17 0.11 Price to Earnings (x) 2.39 -14.03 -31.06 Price to Book (x) 2.78 -22.14 95.47 EV/EBITDA (x) 2.65 -15.74 -31.93 EBITDA Margin (%) 85.66 -447.77 -493.24 InsightsROE Outperforming 5 Year Average
Company delivered ROE of 116.38% in year ending Mar 31, 2026 outperforming its 5 year avg. of 22.05%. (Source: Standalone Financials)
Found Financials useful?
Share Price Forecast
Exclusively for ETPrime
Stock doesn't have any Earning Forecast Data
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
Technicals
No Data Available
- 41%Positive Movement
since 1st Jan 2005
on basis58%Negative Movement
since 1st Jan 2005
on basisExcludeGlobal Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
Mutual Funds Ownership
MF Ownership as on 30 April 2026
25.29
Amount Invested (in Cr.)
0.37916293%
% of AUM
-32.17
% Change (MoM basis)
Motilal Oswal Nifty Microcap 250 Index Direct-G
Equity: Small Cap3.93
Amount Invested (in Cr.)
0.17%
% of AUM
-2.23
% Change (MoM basis)
Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma0.04
Amount Invested (in Cr.)
0.09582%
% of AUM
-3.67
% Change (MoM basis)
Sun Pharma Adv Res. Top Searches
Corporate Actions
Board Meeting
Audited Results
May 11, 2026
Board Meeting
Quarterly Results
Feb 03, 2026
General Meeting
-
Jan 19, 2026
Announced on Meeting on May 11, 2026 May 18, 2026 Audited Results Feb 03, 2026 Feb 09, 2026 Quarterly Results Jan 12, 2026 Jan 14, 2026 To consider issue of Warrants & ESOP Oct 31, 2025 Nov 10, 2025 Quarterly Results Jul 28, 2025 Aug 04, 2025 Quarterly Results No Data Available
No Data Available
No Data Available
Announced on Ex-Date May 12, 2015 Mar 16, 2016 Rights ratio: 5 share for every 116 held at a price of Rs 245.0 Jul 14, 2011 Aug 23, 2012 Rights ratio: 1 share for every 7 held at a price of Rs 67.0 Announced on Meeting on Jan 19, 2026 Feb 09, 2026 - Jul 08, 2025 Aug 12, 2025 - Jul 08, 2024 Aug 12, 2024 - May 22, 2023 Aug 07, 2023 - Aug 08, 2022 Sep 22, 2022 -
About Sun Pharma Adv Res.
Industry
Key Indices Listed On
BSE 250 SmallCap Index, BSE SmallCap, BSE Healthcare, BSE 400 MidSmallCap Index, BSE AllCap
Address
Plot No. 5 & 6/1, Savli G.I.D.C. Estate,Savli - Vadodara Highway,Manjusar,Vadodra District, Gujarat - 391775
Executive Leadership
DS
Dilip S Shanghvi
Chairman & Non-Exe.DirectorAR
Anilkumar Raghavan
Chief Executive OfficerTR
T Rajamannar
Non Executive DirectorVS
Vidhi Shanghvi
Non Executive DirectorShow More
Auditors
S R B C & Co. LLP
FAQs about Sun Pharma Adv Res. share
- 1. What's Sun Pharma Adv Res. share price today and what are Sun Pharma Adv Res. share returns ?Sun Pharma Adv Res. share price is Rs 204.11 as on 11 Jun, 2026, 03:59 PM IST. Sun Pharma Adv Res. share price is down by 0.88% based on previous share price of Rs. 209.19.
- 2. What are the returns for Sun Pharma Adv Res. share?Return Performance of Sun Pharma Adv Res. Shares:
- 1 Week: Sun Pharma Adv Res. share price moved down by 4.16%
- 3. What is the market cap of Sun Pharma Adv Res.?Within the Pharmaceuticals sector, Sun Pharma Adv Res. stock has a market cap rank of 56. Sun Pharma Adv Res. has a market cap of Rs 6,623.81 Cr.
- 4. What is the PE & PB ratio of Sun Pharma Adv Res.?The PE ratio of Sun Pharma Adv Res. stands at 4.3, while the PB ratio is 4.99.
- 5. What is 52 week high/low of Sun Pharma Adv Res. share price?Sun Pharma Adv Res. share price saw a 52 week high of Rs 248.75 and 52 week low of Rs 108.00.
Top Gainers
As on 03:59 PM | 11 Jun 2026Top Losers
As on 03:59 PM | 11 Jun 2026Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.